US Stock MarketDetailed Quotes

PHIO Phio Pharmaceuticals

Watchlist
  • 1.7600
  • +0.0200+1.15%
Close Dec 20 16:00 ET
  • 1.6601
  • -0.0999-5.68%
Post 19:57 ET
2.63MMarket Cap-0.18P/E (TTM)

Phio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-42.72%1.59M
-24.85%1.91M
-38.67%2.21M
-6.67%10.7M
-35.05%1.77M
-22.26%2.78M
1.03%2.55M
36.44%3.6M
-15.17%11.46M
-20.87%2.73M
Selling and administrative expenses
-2.27%946K
-9.97%1.05M
-27.72%1.06M
-1.89%4.37M
-31.36%766K
-8.94%968K
-4.35%1.16M
39.28%1.47M
-3.78%4.45M
-8.90%1.12M
-General and administrative expense
-2.27%946K
-9.97%1.05M
-27.72%1.06M
-1.89%4.37M
-31.36%766K
-8.94%968K
-4.35%1.16M
39.28%1.47M
-3.78%4.45M
-8.90%1.12M
Research and development costs
-64.38%644K
-37.38%866K
-46.20%1.15M
-9.70%6.33M
-37.61%1.01M
-27.91%1.81M
6.06%1.38M
34.55%2.13M
-21.09%7.01M
-27.46%1.61M
Operating profit
42.72%-1.59M
24.85%-1.91M
38.67%-2.21M
6.67%-10.7M
35.05%-1.77M
22.26%-2.78M
-1.03%-2.55M
-36.44%-3.6M
15.17%-11.46M
20.87%-2.73M
Net non-operating interest income expense
Other net income (expense)
1,750.00%66K
3,500.00%68K
55K
-611.11%-128K
-12,100.00%-122K
20.00%-4K
80.00%-2K
-108.04%-18K
0.00%-1K
Special income (charges)
----
----
----
---126K
----
----
----
----
--0
----
-Less:Impairment of capital assets
----
----
----
--126K
----
----
----
----
--0
----
Other non- operating income (expenses)
1,750.00%66K
3,500.00%68K
--55K
88.89%-2K
500.00%4K
20.00%-4K
80.00%-2K
----
-108.04%-18K
0.00%-1K
Income before tax
45.18%-1.52M
27.58%-1.85M
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
Income tax
Net income
45.18%-1.52M
27.58%-1.85M
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
Net income continuous Operations
45.18%-1.52M
27.58%-1.85M
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
Minority interest income
Net income attributable to the parent company
45.18%-1.52M
27.58%-1.85M
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
45.18%-1.52M
27.58%-1.85M
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
Basic earnings per share
84.98%-1.54
72.72%-3.62
85.08%-4.23
48.51%-46.8
92.96%-1.52
63.73%-10.25
33.58%-13.27
-34.62%-28.35
18.71%-90.9
21.70%-21.6
Diluted earnings per share
84.98%-1.54
72.72%-3.62
85.08%-4.23
48.51%-46.8
92.96%-1.52
63.73%-10.25
33.58%-13.27
-34.62%-28.35
18.71%-90.9
21.70%-21.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -42.72%1.59M-24.85%1.91M-38.67%2.21M-6.67%10.7M-35.05%1.77M-22.26%2.78M1.03%2.55M36.44%3.6M-15.17%11.46M-20.87%2.73M
Selling and administrative expenses -2.27%946K-9.97%1.05M-27.72%1.06M-1.89%4.37M-31.36%766K-8.94%968K-4.35%1.16M39.28%1.47M-3.78%4.45M-8.90%1.12M
-General and administrative expense -2.27%946K-9.97%1.05M-27.72%1.06M-1.89%4.37M-31.36%766K-8.94%968K-4.35%1.16M39.28%1.47M-3.78%4.45M-8.90%1.12M
Research and development costs -64.38%644K-37.38%866K-46.20%1.15M-9.70%6.33M-37.61%1.01M-27.91%1.81M6.06%1.38M34.55%2.13M-21.09%7.01M-27.46%1.61M
Operating profit 42.72%-1.59M24.85%-1.91M38.67%-2.21M6.67%-10.7M35.05%-1.77M22.26%-2.78M-1.03%-2.55M-36.44%-3.6M15.17%-11.46M20.87%-2.73M
Net non-operating interest income expense
Other net income (expense) 1,750.00%66K3,500.00%68K55K-611.11%-128K-12,100.00%-122K20.00%-4K80.00%-2K-108.04%-18K0.00%-1K
Special income (charges) ---------------126K------------------0----
-Less:Impairment of capital assets --------------126K------------------0----
Other non- operating income (expenses) 1,750.00%66K3,500.00%68K--55K88.89%-2K500.00%4K20.00%-4K80.00%-2K-----108.04%-18K0.00%-1K
Income before tax 45.18%-1.52M27.58%-1.85M40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M
Income tax
Net income 45.18%-1.52M27.58%-1.85M40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M
Net income continuous Operations 45.18%-1.52M27.58%-1.85M40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M
Minority interest income
Net income attributable to the parent company 45.18%-1.52M27.58%-1.85M40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 45.18%-1.52M27.58%-1.85M40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M
Basic earnings per share 84.98%-1.5472.72%-3.6285.08%-4.2348.51%-46.892.96%-1.5263.73%-10.2533.58%-13.27-34.62%-28.3518.71%-90.921.70%-21.6
Diluted earnings per share 84.98%-1.5472.72%-3.6285.08%-4.2348.51%-46.892.96%-1.5263.73%-10.2533.58%-13.27-34.62%-28.3518.71%-90.921.70%-21.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List